Clinical Trials on Obesity; Drug in Hong Kong
Total 95 results
-
University of California, Los AngelesNational Institute on Drug Abuse (NIDA); Medical University of South Carolina; University of ArkansasRecruitingDrug UseUnited States
-
Universiti Sultan Zainal AbidinRecruitingChildhood Obesity PreventionMalaysia
-
University Hospital Inselspital, BerneCompletedDrug-Eluting Stents | Coronary Thrombosis | Tomography, Optical CoherenceAustria, Belgium, France, Germany, Hong Kong, Italy, Netherlands, Singapore, Spain, Switzerland
-
MemorialCare Health SystemUniversity of California, IrvineCompletedCesarean Section | Obesity, SevereUnited States
-
MemorialCare Health SystemUniversity of California, IrvineCompletedObesity | Pregnancy | Obesity, Morbid | Infection; Cesarean SectionUnited States
-
SanofiCompletedObesity | DyslipidemiaUnited States, Canada, Brazil, Australia, Italy, Sweden, Malaysia, Singapore, Taiwan, Mexico, Denmark, Korea, Republic of, Hong Kong, South Africa
-
Pusan National University Yangsan HospitalCompletedObesity | OverweightKorea, Republic of
-
MemorialCare Health SystemCompletedObesity | Pregnancy | Venous Thromboembolism | Obesity, Morbid | Pulmonary Embolism | Complications; Cesarean Section | Postpartum Deep PhlebothrombosisUnited States
-
National OncoVentureHanmi Pharmaceutical Company LimitedCompletedIncreased Drug ResistanceKorea, Republic of
-
University of California, Los AngelesPatient-Centered Outcomes Research InstituteCompletedObesityUnited States
-
Kyunghee University Medical CenterUnknown
-
MemorialCareUniversity of California, IrvineCompleted
-
VA Office of Research and DevelopmentCompletedObesity | Diabetes | Weight GainUnited States
-
Novo Nordisk A/SCompletedObesity | Diabetes Mellitus, Type 2 | OverweightKorea, Republic of, Hong Kong, Brazil, China
-
Rutgers, The State University of New JerseyRecruitingCardiac Toxicity | Early-stage Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedObesity | Colorectal Cancer | Adenomatous PolypCanada, United States
-
ANRS, Emerging Infectious DiseasesUniversité Montpellier; Haiphong University of Medicine and Pharmacy; Centre... and other collaboratorsActive, not recruitingDrug Use | Psychiatric DisorderVietnam
-
AstraZenecaCompletedObesity | OverweightUnited States
-
ANRS, Emerging Infectious DiseasesCompletedHepatitis C | Viral Hepatitis C | Drug UseVietnam
-
Eisai Inc.Terminated
-
University of HawaiiQueen's Medical Center; I Ola Lahui, Inc.; Ke Ola Mamo; Queen Lili'uokalani Children... and other collaboratorsCompletedObesity | Overweight | Weight Loss | Weight Loss MaintenanceUnited States
-
Neurocrine BiosciencesEvideraUnknownTardive DyskinesiaUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
Neurocrine BiosciencesCompletedTardive DyskinesiaUnited States, Canada, Puerto Rico
-
AmgenActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, Czechia, Taiwan, Canada, Japan, Korea, Republic of, Germany, Hungary, Australia, Hong Kong, Spain, Poland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedColorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation EnteritisUnited States
-
Neurocrine BiosciencesCompletedTardive DyskinesiaUnited States, Canada, Puerto Rico
-
Children's Oncology GroupNational Cancer Institute (NCI); Children's Cancer GroupCompletedLymphoma | Cardiac ToxicityUnited States, Australia, Canada
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Eli Lilly and CompanyRecruitingOverweight and ObesityUnited States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, India, Israel, Italy, United Kingdom, Spain, France, Sweden, Taiwan, Turkey, Germany, South Africa, Puerto Rico
-
Eli Lilly and CompanyActive, not recruitingObesity | OverweightSpain, United States, Australia, Italy, Hungary, India, Israel, Canada, China, Taiwan, Japan, United Kingdom, Belgium, France, Germany, Mexico, Romania, Poland, Argentina, Brazil, Puerto Rico, Austria, Turkey, Netherlands, Korea, Republic... and more
-
Boehringer IngelheimRecruitingObesityUnited States, Korea, Republic of, Belgium, Australia, United Kingdom, Mexico, Spain, Germany, Taiwan, Netherlands, Brazil, Hungary, Denmark, Canada, Poland, Austria, China, Finland, Greece, Italy, Hong Kong, Czechia, Portugal, Saudi... and more
-
Novo Nordisk A/SCompletedObesity | Metabolism and Nutrition DisorderUnited States, Poland, Israel, Italy, Mexico, Spain, Canada, Denmark, Finland, United Kingdom, France, Netherlands, Austria, Belgium, Argentina, Russian Federation, Serbia, Turkey, Switzerland, Germany, South Africa, Hungary, Hong Kong and more
-
Novo Nordisk A/SCompletedObesity | OverweightUnited States, France, Spain, Taiwan, United Kingdom, Germany, India, Brazil, Canada, Japan, Malaysia, Russian Federation, Australia, Norway, Mexico, Netherlands, Portugal, Hungary, Italy, Austria, Greece, South Africa, Turkey, Finland, Puerto Rico and more
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Czechia, Germany, Argentina, Greece, Slovakia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Cardiac ToxicityUnited States, Canada, Netherlands, Puerto Rico, Switzerland, Australia
-
Eli Lilly and CompanyActive, not recruitingObesity | Overweight | Type 2 DiabetesUnited States, China, Australia, India, Germany, Brazil, Greece, Argentina, Korea, Republic of, Czechia, Puerto Rico
-
Novo Nordisk A/SRecruitingCardiovascular DiseaseNetherlands, Australia, Italy, United States, Serbia, Spain, United Kingdom, Thailand, India, Malaysia, Turkey, Mexico, Canada, Argentina, Germany, France, Poland, South Africa, Brazil, Bulgaria, Colombia, Denmark, Ireland, Japan
-
Eisai Inc.Thrombolysis In Myocardial Infarction (TIMI) Academic Research OrganizationCompletedObesity | Cardiovascular Disease | Overweight | Type 2 Diabetes | High Cardiovascular RiskUnited States, Canada, Poland, Australia, Mexico, New Zealand, Bahamas, Chile
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)UnknownObesity | Fatigue | Stage I Uterine Corpus Cancer AJCC v7 | Stage II Uterine Corpus Cancer AJCC v7 | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Neurotoxicity SyndromeUnited States, Korea, Republic of
-
Novo Nordisk A/SRecruitingObesity | Type 2 Diabetes | Chronic Kidney DiseaseUnited States, Spain, Poland, Thailand, India, France, Argentina, Canada, Japan, Greece, Hungary, Brazil, Slovakia
-
Eli Lilly and CompanyActive, not recruitingUrogenital Neoplasms | Prostatic Neoplasms | Neoplasm Metastasis | Enzyme Inhibitors | Antineoplastic Agents | Hormones | Physiological Effects of Drugs | Antineoplastic Agents, Hormonal | Androgens | Hormones, Hormone Substitutes, and Hormone Antagonists | Abiraterone Acetate | Steroid Synthesis Inhibitors | Cytochrome... and other conditionsChina, Canada, France, United States, Australia, Czechia, Hungary, Spain, Germany, Japan, Taiwan, Netherlands, Turkey, Mexico, Belgium, Korea, Republic of, Argentina, Romania, United Kingdom, Italy, Israel, Brazil, Poland, Greece